Companies: 10,795·Total market cap: $144.5T
Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd. Common Stock

MDCXNASDAQHealthcare● Active
$0.34
$-0.01(-3.94%)
Market Cap$7410165
P/E Ratio
52W High$3.69
52W Low$0.25

Medicus Pharma Ltd. Common Stock(MDCX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

mdcx · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 100.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.34

Medicus Pharma Ltd. Common Stock(MDCX)的分析师共识为 Buy,基于过去 3 个月内 2 位华尔街分析师的评级。MDCX 的 12 个月平均目标价为 $0.00,相对当前价 $0.34 代表 +0.0% 的潜在上行空间。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.355.00%

1-day model range: $0.35–$0.36. Peak: $0.36 (+5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

21%36%43%
3Buy
5Neutral
6Sell
RSI (14)58.7Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MDCX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.35SELL
MA 10$0.34SELL
MA 20$0.32BUY
MA 50$0.35SELL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $MDCX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.35SELL
EMA 10$0.34SELL
EMA 20$0.33BUY
EMA 50$0.37SELL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $MDCX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
D. Boral Capital2026-04-20
Maintains
BuyBuy
D. Boral Capital2026-03-19
Maintains
BuyBuy
D. Boral Capital2026-03-09
Maintains
BuyBuy
D. Boral Capital2025-12-15
Maintains
BuyBuy
D. Boral Capital2025-11-17
Maintains
BuyBuy
D. Boral Capital2025-11-13
Maintains
BuyBuy
D. Boral Capital2025-10-29
Maintains
BuyBuy
D. Boral Capital2025-10-22
Maintains
BuyBuy
D. Boral Capital2025-10-14
Maintains
BuyBuy
D. Boral Capital2025-09-29
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Medicus Pharma Ltd. Common Stock (MDCX) stock. Of the recent 23 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover MDCX.

分析师推荐趋势

Buy ratings211
Hold ratings00
Sell ratings00

MDCX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

↓ 99.8% YoY

Revenue Next Year

$0M

↓ 100.0% YoY

EPS This Year

$-0.52

EPS Next Year

$-0.39

↓ 23.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MDCX EPS of $-0.52 for the current fiscal year, based on estimates from 1 analysts. The MDCX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

MDCX 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MDCX 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

MDCX 的短期预测(明日)为 $0.35(+5.00%)。

Medicus Pharma Ltd. Common Stock 在 NASDAQ 上市,代码 MDCX。MDCX 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

MDCX 预测 · 8 个问题

根据 2 位华尔街分析师,MDCX 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $0.34,隐含约 +0.0% 的上行空间。

MDCX 目标价MDCX 分析师目标价MDCX 12个月目标价目标价 MDCX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.